Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy

D E Orange; M Jegathesan; N E Blachère; M O Frank; H I Scher; M L Albert; R B Darnell

doi:10.1038/sj.pcan.4500694

Journal articles

Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy

D E Orange ¹ M Jegathesan ¹ N E Blachère ¹ M O Frank ¹ H I Scher ² M L Albert ¹ R B Darnell ¹

1 Laboratory of Molecular Neuro-oncology

2 Division of Solid Tumor Oncology [New York]

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Immunology

Complete list of metadatas

https://hal-pasteur.archives-ouvertes.fr/pasteur-01402399
Contributor : Marie-Christine Vougny <>
Submitted on : Thursday, November 24, 2016 - 4:03:00 PM
Last modification on : Friday, April 3, 2020 - 9:42:36 AM

Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy

Links full text

Identifiers

Citation

Export

Metrics

16

Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy

Links full text

Identifiers

Citation

Export

Share

Metrics

16